Maxence Compagnat1, Stéphane Mandigout2, Anaick Perrochon2, Justine Lacroix2, Nicolas Vuillerme3, Jean Yves Salle4, Jean Christophe Daviet4. 1. HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), IFRH, University of Limoges, Limoges, France; Department of Physical Medicine and Rehabilitation in the University Hospital Center of Limoges, Limoges, France. Electronic address: maxence.compagnat@unilim.fr. 2. HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), IFRH, University of Limoges, Limoges, France. 3. AGEIS, University Grenoble Alpes, Grenoble, France. 4. HAVAE EA6310 (Handicap, Aging, Autonomy, Environment), IFRH, University of Limoges, Limoges, France; Department of Physical Medicine and Rehabilitation in the University Hospital Center of Limoges, Limoges, France.
Abstract
OBJECTIVE: To evaluate the association between self-selected walking speed (Sfree), oxygen consumption at Sfree (Vo2free), the oxygen cost of walking (Cw) at Sfree, and mobility independence and independence for activities of daily living in individuals poststroke. DESIGN: Cross-sectional study. SETTING: Hospital. PARTICIPANTS: Individuals with stroke who were able to walk without human assistance were included. We included 90 individuals (N=90; mean age, 63.5±14.0y). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Cw was captured during walking from measurements of Sfree and Vo2free. We assessed mobility independence based on the modified Functional Ambulation Classification (mFAC) and independence in activities of daily living by the Barthel Index (BI). Multiple linear regression analyses were performed to evaluate the independence of Cw, Vo2free, and Sfree from the determination of BI and mFAC among the various characteristics of the population (age, stroke delay, body mass index, motor function, spasticity). RESULTS: We reported Cw=0.36 mL/kg/m (interquartile range [IQR]=0.28 mL/kg/m), Sfree=0.60±0.32 m/s, Vo2free=11.2 mL/kg/min (IQR=1.8 mL/kg/min). The multiple linear regression analyses showed that Cw and Sfree were independently associated with the BI (P<.01) and the mFAC (P<.01) scores. Vo2free was not found to be an explanatory variable of functional independence (P>.05). CONCLUSIONS: Cw was independently associated with functional independence. This association appears to be primarily determined by Sfree and not Vo2free, underscoring the importance of evaluating and acting on Sfree to improve the functional independence of individuals with stroke.
OBJECTIVE: To evaluate the association between self-selected walking speed (Sfree), oxygen consumption at Sfree (Vo2free), the oxygen cost of walking (Cw) at Sfree, and mobility independence and independence for activities of daily living in individuals poststroke. DESIGN: Cross-sectional study. SETTING: Hospital. PARTICIPANTS: Individuals with stroke who were able to walk without human assistance were included. We included 90 individuals (N=90; mean age, 63.5±14.0y). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Cw was captured during walking from measurements of Sfree and Vo2free. We assessed mobility independence based on the modified Functional Ambulation Classification (mFAC) and independence in activities of daily living by the Barthel Index (BI). Multiple linear regression analyses were performed to evaluate the independence of Cw, Vo2free, and Sfree from the determination of BI and mFAC among the various characteristics of the population (age, stroke delay, body mass index, motor function, spasticity). RESULTS: We reported Cw=0.36 mL/kg/m (interquartile range [IQR]=0.28 mL/kg/m), Sfree=0.60±0.32 m/s, Vo2free=11.2 mL/kg/min (IQR=1.8 mL/kg/min). The multiple linear regression analyses showed that Cw and Sfree were independently associated with the BI (P<.01) and the mFAC (P<.01) scores. Vo2free was not found to be an explanatory variable of functional independence (P>.05). CONCLUSIONS: Cw was independently associated with functional independence. This association appears to be primarily determined by Sfree and not Vo2free, underscoring the importance of evaluating and acting on Sfree to improve the functional independence of individuals with stroke.